Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial

Karine Buchet-Poyau, Pauline Occelli, Sandrine Touzet, Carole Langlois-Jacques, Sophie Figon, Jean-Pierre Dubois, Antoine Duclos, Marc Chanelière, Cyrille Colin, Muriel Rabilloud, Maud Keriel-Gascou, Karine Buchet-Poyau, Pauline Occelli, Sandrine Touzet, Carole Langlois-Jacques, Sophie Figon, Jean-Pierre Dubois, Antoine Duclos, Marc Chanelière, Cyrille Colin, Muriel Rabilloud, Maud Keriel-Gascou

Abstract

Background: About 25% of patients experience adverse drug events (ADE) in primary care, but few events are reported by the patients themselves. One solution to improve the detection and management of ADEs in primary care is for patients to report them to their general practitioner. The study aimed to assess the effect of a booklet designed to improve communication and interaction between patients treated with anti-hypertensive drugs and general practitioners on the reporting of ADEs.

Methods: A cluster randomized controlled cross-sectional stepped wedge open trial (five periods of 3 months) was conducted. A cluster was a group of general practitioners working in ambulatory offices in France. Adults consulting their general practitioner to initiate, modify, or renew an antihypertensive prescription were included. A booklet including information on cardiovascular risks, antihypertensive treatments, and ADE report forms was delivered by the general practitioner to the patient in the intervention group. The primary outcome was the reporting of at least one ADE by the patient to his general practitioner during the three-month period after enrolment. Two clusters were randomised by sequence for a total of 8 to receive the intervention. An intention-to-treat analysis was conducted. A logistic mixed model with random intercept was used.

Results: Sixty general practitioners included 1095 patients (median: 14 per general practitioner; range: 1-103). More patients reported at least one ADE to their general practitioner in the intervention condition compared to the control condition (aOR = 3.5, IC95 [1.2-10.1], p = 0.02). The modification and initiation of an antihypertensive treatment were also significantly associated with the reporting of ADEs (aOR = 4.4, CI95 [1.9-10.0], p < 0.001 and aOR = 11.0, CI95 [4.6-26.4], p < 0.001, respectively). The booklet delivery also improved patient satisfaction on general practitioner communication and high blood pressure management.

Conclusion: A booklet can improve patient self-reporting of ADEs to their general practitioners. Future research should assess whether it can improve general practitioner management of ADEs and patient's health status.

Trial registration: Trial registry identifier NCT01610817 (2012/05/30).

Keywords: Adverse drug events; Antihypertensive drugs; Educational booklet; Family medicine; Patient safety; Patient-centred care; Stepped wedge cluster trial.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

References

    1. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–1564. doi: 10.1056/NEJMsa020703.
    1. Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother. 2011;45(7-8):977–989. doi: 10.1345/aph.1P627.
    1. Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8:e019101. doi: 10.1136/bmjopen-2017-019101.
    1. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–1116. doi: 10.1001/jama.289.9.1107.
    1. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med. 2005;118(3):251–258. doi: 10.1016/j.amjmed.2004.09.018.
    1. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–i59. doi: 10.1093/intqhc/mzg085.
    1. Krein SL, Saint S, Trautner BW, Kuhn L, Colozzi J, Ratz D, Lescinskas E, Chopra V. Patient-reported complications related to peripherally inserted central catheters: a multicentre prospective cohort study. BMJ Qual Saf. 2019;28(7):574–581. doi: 10.1136/bmjqs-2018-008726.
    1. de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31(6):515–524. doi: 10.2165/00002018-200831060-00006.
    1. Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. BMJ. 1998;316(7149):1948–1952. doi: 10.1136/bmj.316.7149.1948.
    1. Little P, Somerville J, Williamson I, Warner G, Moore M, Wiles R, George S, Smith A, Peveler R. Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ. 2001;322(7296):1214–1217. doi: 10.1136/bmj.322.7296.1214.
    1. Little P, Dorward M, Warner G, Moore M, Stephens K, Senior J, Kendrick T. Randomised controlled trial of effect of leaflets to empower patients in consultations in primary care. BMJ. 2004;328(7437):441. doi: 10.1136/bmj.37999.716157.44.
    1. Fick DM, Maclean JR, Rodriguez NA, Short L, Heuvel RV, Waller JL, Rogers RL. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag Care. 2004;10(11 Pt 1):761–768.
    1. Roughead E, Pratt N, Peck R, Gilbert A. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf. 2007;16(7):797–803. doi: 10.1002/pds.1393.
    1. Dawes MG, Kaczorowski J, Swanson G, Hickey J, Karwalajtys T. The effect of a patient education booklet and BP “tracker” on knowledge about hypertension. A randomized controlled trial. Fam Pract. 2010;27(5):472–478. doi: 10.1093/fampra/cmq048.
    1. de Bont EG, Alink M, Falkenberg FC, Dinant GJ, Cals JW. Patient information leaflets to reduce antibiotic use and reconsultation rates in general practice: a systematic review. BMJ Open. 2015;5(6):e007612. doi: 10.1136/bmjopen-2015-007612.
    1. Keriel-Gascou M, Badet-Phan A, Le Pogam MA, Figon S, Letrilliart L, Gueyffier F, Chanelière M, Buchet-Poyau K, Duclos A, Colin C. Information and active patient participation using an interactive booklet in the prescription of antihypertensive drugs in primary care. Santé Publique. 2013;25:193–201. doi: 10.3917/spub.132.0193.
    1. Keriel-Gascou M, Buchet-Poyau K, Duclos A, Rabilloud M, Figon S, Dubois JP, Brami J, Vial T, Colin C. Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial. Implement Sci. 2013;8(1):69–76. doi: 10.1186/1748-5908-8-69.
    1. Keriel-Gascou M, Buchet-Poyau K, Rabilloud M, Duclos A, Colin C. A stepped wedge cluster randomized trial is preferable for assessing complex health interventions. J Clin Epidemiol. 2014;67(7):831–833. doi: 10.1016/j.jclinepi.2014.02.016.
    1. Lainer M, Vögele A, Wensing M, Sönnichsen A. Improving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care. Eur J Gen Pract. 2015;21(sup1):14–18. doi: 10.3109/13814788.2015.1043124.
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182–191. doi: 10.1016/j.cct.2006.05.007.
    1. Hemming K, Taljaard M, McKenzie JE, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018;363:k1614. doi: 10.1136/bmj.k1614.
    1. Zhang NJ, Terry A, McHorney CA. Impact of health literacy on medication adherence: a systematic review and meta-analysis. Ann Pharmacother. 2014;48(6):741–751. doi: 10.1177/1060028014526562.
    1. Mosher HJ, Lund BC, Kripalani S, Kaboli PJ. Association of health literacy with medication knowledge, adherence, and adverse drug events among elderly veterans. J Health Commun. 2012;17(Suppl 3):241–251. doi: 10.1080/10810730.2012.712611.
    1. Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015;351:h4672. doi: 10.1136/bmj.h4672.
    1. Rosendal M, Jarbøl DE, Pedersen AF, Andersen RS. Multiple perspectives on symptom interpretation in primary care research. BMC Fam Pract. 2013;14(1):167. doi: 10.1186/1471-2296-14-167.
    1. Lang S, Velasco Garrido M, Heintze C. Patients’ views of adverse events in primary and ambulatory care: a systematic review to assess methods and the content of what patients consider to be adverse events. BMC Fam Pract. 2016;17(1):6. doi: 10.1186/s12875-016-0408-0.
    1. van Beusekom MM, Grootens-Wiegers P, Bos MJ, Guchelaar HJ, van den Broek JM. Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images. Int J Clin Pharm. 2016;38(6):1372–1379. doi: 10.1007/s11096-016-0376-4.
    1. Rao JK, Anderson LA, Inui TS, Frankel RM. Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence. Med Care. 2007;45(4):340–349. doi: 10.1097/01.mlr.0000254516.04961.d5.
    1. Weingart SN, Hamrick HE, Tutkus S, Carbo A, Sands DZ, Tess A, Davis RB, Bates DW, Phillips RS. Medication safety messages for patients via the web portal: the MedCheck intervention. Int J Med Inform. 2008;77(3):161–168. doi: 10.1016/j.ijmedinf.2007.04.007.
    1. Weingart SN, Carbo A, Tess A, Chiappetta L, Tutkus S, Morway L, Toth M, Davis RB, Phillips RS, Bates DW. Using a patient internet portal to prevent adverse drug events: a randomized, controlled trial. J Patient Saf. 2013;9(3):169–175. doi: 10.1097/PTS.0b013e31829e4b95.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren